Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Schema
  9. External Links
  10. Analytics And Tracking
  11. Libraries
  12. CDN Services

We are analyzing https://link.springer.com/article/10.1186/s12858-015-0042-9.

Title:
The androgen receptor plays a suppressive role in epithelial- mesenchymal transition of human prostate cancer stem progenitor cells | BMC Biochemistry
Description:
Background To investigate the roles of androgen receptor (AR) in epithelial- mesenchymal transition (EMT) in human prostate cancer stem progenitor (S/P) cells isolated from LNCaP cell line. Methods The S/P cells were obtained from LNCaP cell line through florescence-activated cell sorting (FACS). AR was overexpressed in S/P cells through lentivirus. Western blot assay was used to detect the EMT markers expression, such as E Cadherin, N Cadherin, Vimentin and Snail. MTT assay, soft agar colony formation assay, sphere formation assay and migration assay were used to investigate AR’s roles in EMT of S/P cells. Cell signaling pathways associated with proliferation and apoptosis of S/P cells were detected simultaneously. And S/P cells were treated with in vitro combinatory use of LY 294002 (inhibitor of AKT signaling molecules) with γ-TT and/or 5-AZA. Results Our data showed that S/P cells from LNCaP had high EMT markers expression, more tumorigenesis and strong migration ability. And in S/P cells overexpressed with AR, the expression of EMT markers decreased. In addition, these cells had less proliferation ability, tumorigenesis ability, self-renewal and migration ability. At the same time, targeting S/P cells with AKT signaling pathway inhibitor LY29004 andγ-TT and/or 5-AZA could inhibit S/P cell’s proliferation and tumorigenesis. Conclusions Our data suggest that AR played a negative role in EMT of PCa S/P cells, by regulating AKT cell signaling pathway, which could be a new strategy to treat castration resistant prostate cancer (CRPC).
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Science
  • Education
  • Health & Fitness

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We don't see any clear sign of profit-making.

While many websites aim to make money, others are created to share knowledge or showcase creativity. People build websites for various reasons. This could be one of them. Link.springer.com might be cashing in, but we can't detect the method they're using.

Keywords {🔍}

cells, cancer, cell, prostate, emt, pubmed, article, google, scholar, signaling, expression, assay, stem, cas, lncap, markers, figure, androgen, epithelial, transition, proliferation, cadherin, central, analysis, receptor, akt, bcl, pathways, pca, human, line, agar, tumor, medium, days, formation, cmyc, incubated, role, related, min, data, western, showed, ability, metastasis, characteristics, staining, antibodies, research,

Topics {✒️}

c-jun-dependent transcriptional activation bmp7-induced epithelial-mesenchymal transition inhibits epithelial-mesenchymal transition wnt/β-catenin signal network wu nan & zhang shuhai prostate cancer stem/progenitor pi3k/akt/mtor pathway open access license article download pdf pten/akt/pi3k signaling prostate stem/progenitor cells cancer stem/progenitor cells florescence-activated cell sorting single-color positive controls docetaxel-resistant pca cells c-myc sirna plasmids egfr-mediated erk signaling epithelial- mesenchymal transition epithelial-mesenchymal transition hrp-conjugated secondary antibodies proliferation include pi3k/akt qrt-pcr analysis results proteins expression quantitative pcr analysis soft agar assay wnt signaling regulates sphere formation assay cancer stem cell cancer stem cell epithelial cell marker cell stem cell cancer treat rev erk signaling pathway prostate basal epithelial privacy choices/manage cookies stem/progenitor cells stem/progenitor cells notch1 signaling pathway cell signaling pathways related signaling pathways signaling pathways related 5% low-melting agar early prostate cancer metastatic prostate cancer prostate cancer radioresistance prostate cancer fails maintain stem cell pi3k/akt signaling bio-rad laboratories akt signaling molecules

Schema {🗺️}

WebPage:
      mainEntity:
         headline:The androgen receptor plays a suppressive role in epithelial- mesenchymal transition of human prostate cancer stem progenitor cells
         description:To investigate the roles of androgen receptor (AR) in epithelial- mesenchymal transition (EMT) in human prostate cancer stem progenitor (S/P) cells isolated from LNCaP cell line. The S/P cells were obtained from LNCaP cell line through florescence-activated cell sorting (FACS). AR was overexpressed in S/P cells through lentivirus. Western blot assay was used to detect the EMT markers expression, such as E Cadherin, N Cadherin, Vimentin and Snail. MTT assay, soft agar colony formation assay, sphere formation assay and migration assay were used to investigate AR’s roles in EMT of S/P cells. Cell signaling pathways associated with proliferation and apoptosis of S/P cells were detected simultaneously. And S/P cells were treated with in vitro combinatory use of LY 294002 (inhibitor of AKT signaling molecules) with γ-TT and/or 5-AZA. Our data showed that S/P cells from LNCaP had high EMT markers expression, more tumorigenesis and strong migration ability. And in S/P cells overexpressed with AR, the expression of EMT markers decreased. In addition, these cells had less proliferation ability, tumorigenesis ability, self-renewal and migration ability. At the same time, targeting S/P cells with AKT signaling pathway inhibitor LY29004 andγ-TT and/or 5-AZA could inhibit S/P cell’s proliferation and tumorigenesis. Our data suggest that AR played a negative role in EMT of PCa S/P cells, by regulating AKT cell signaling pathway, which could be a new strategy to treat castration resistant prostate cancer (CRPC).
         datePublished:2015-05-06T00:00:00Z
         dateModified:2015-05-06T00:00:00Z
         pageStart:1
         pageEnd:11
         license:http://creativecommons.org/publicdomain/zero/1.0/
         sameAs:https://doi.org/10.1186/s12858-015-0042-9
         keywords:
            Prostatic neoplasms
            Stem progenitor cell
            Epithelial-mesenchymal transition
            Androgen receptor
            Biochemistry
            general
            Life Sciences
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12858-015-0042-9/MediaObjects/12858_2015_42_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12858-015-0042-9/MediaObjects/12858_2015_42_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12858-015-0042-9/MediaObjects/12858_2015_42_Fig3_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12858-015-0042-9/MediaObjects/12858_2015_42_Fig4_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12858-015-0042-9/MediaObjects/12858_2015_42_Fig5_HTML.gif
         isPartOf:
            name:BMC Biochemistry
            issn:
               1471-2091
            volumeNumber:16
            type:
               Periodical
               PublicationVolume
         publisher:
            name:BioMed Central
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Ma Zhifang
               affiliation:
                     name:First Hospital of Shanxi Medical University
                     address:
                        name:Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Wei Liang
               affiliation:
                     name:First Hospital of Shanxi Medical University
                     address:
                        name:Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Zhang Wei
               affiliation:
                     name:First Hospital of Shanxi Medical University
                     address:
                        name:Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Hao Bin
               affiliation:
                     name:First Hospital of Shanxi Medical University
                     address:
                        name:Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Tu Rui
               affiliation:
                     name:First Hospital of Shanxi Medical University
                     address:
                        name:Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Wu Nan
               affiliation:
                     name:First Hospital of Shanxi Medical University
                     address:
                        name:Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Zhang Shuhai
               affiliation:
                     name:First Hospital of Shanxi Medical University
                     address:
                        name:Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, China
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:The androgen receptor plays a suppressive role in epithelial- mesenchymal transition of human prostate cancer stem progenitor cells
      description:To investigate the roles of androgen receptor (AR) in epithelial- mesenchymal transition (EMT) in human prostate cancer stem progenitor (S/P) cells isolated from LNCaP cell line. The S/P cells were obtained from LNCaP cell line through florescence-activated cell sorting (FACS). AR was overexpressed in S/P cells through lentivirus. Western blot assay was used to detect the EMT markers expression, such as E Cadherin, N Cadherin, Vimentin and Snail. MTT assay, soft agar colony formation assay, sphere formation assay and migration assay were used to investigate AR’s roles in EMT of S/P cells. Cell signaling pathways associated with proliferation and apoptosis of S/P cells were detected simultaneously. And S/P cells were treated with in vitro combinatory use of LY 294002 (inhibitor of AKT signaling molecules) with γ-TT and/or 5-AZA. Our data showed that S/P cells from LNCaP had high EMT markers expression, more tumorigenesis and strong migration ability. And in S/P cells overexpressed with AR, the expression of EMT markers decreased. In addition, these cells had less proliferation ability, tumorigenesis ability, self-renewal and migration ability. At the same time, targeting S/P cells with AKT signaling pathway inhibitor LY29004 andγ-TT and/or 5-AZA could inhibit S/P cell’s proliferation and tumorigenesis. Our data suggest that AR played a negative role in EMT of PCa S/P cells, by regulating AKT cell signaling pathway, which could be a new strategy to treat castration resistant prostate cancer (CRPC).
      datePublished:2015-05-06T00:00:00Z
      dateModified:2015-05-06T00:00:00Z
      pageStart:1
      pageEnd:11
      license:http://creativecommons.org/publicdomain/zero/1.0/
      sameAs:https://doi.org/10.1186/s12858-015-0042-9
      keywords:
         Prostatic neoplasms
         Stem progenitor cell
         Epithelial-mesenchymal transition
         Androgen receptor
         Biochemistry
         general
         Life Sciences
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12858-015-0042-9/MediaObjects/12858_2015_42_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12858-015-0042-9/MediaObjects/12858_2015_42_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12858-015-0042-9/MediaObjects/12858_2015_42_Fig3_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12858-015-0042-9/MediaObjects/12858_2015_42_Fig4_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12858-015-0042-9/MediaObjects/12858_2015_42_Fig5_HTML.gif
      isPartOf:
         name:BMC Biochemistry
         issn:
            1471-2091
         volumeNumber:16
         type:
            Periodical
            PublicationVolume
      publisher:
         name:BioMed Central
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Ma Zhifang
            affiliation:
                  name:First Hospital of Shanxi Medical University
                  address:
                     name:Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Wei Liang
            affiliation:
                  name:First Hospital of Shanxi Medical University
                  address:
                     name:Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Zhang Wei
            affiliation:
                  name:First Hospital of Shanxi Medical University
                  address:
                     name:Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Hao Bin
            affiliation:
                  name:First Hospital of Shanxi Medical University
                  address:
                     name:Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Tu Rui
            affiliation:
                  name:First Hospital of Shanxi Medical University
                  address:
                     name:Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Wu Nan
            affiliation:
                  name:First Hospital of Shanxi Medical University
                  address:
                     name:Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Zhang Shuhai
            affiliation:
                  name:First Hospital of Shanxi Medical University
                  address:
                     name:Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, China
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:BMC Biochemistry
      issn:
         1471-2091
      volumeNumber:16
Organization:
      name:BioMed Central
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:First Hospital of Shanxi Medical University
      address:
         name:Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, China
         type:PostalAddress
      name:First Hospital of Shanxi Medical University
      address:
         name:Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, China
         type:PostalAddress
      name:First Hospital of Shanxi Medical University
      address:
         name:Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, China
         type:PostalAddress
      name:First Hospital of Shanxi Medical University
      address:
         name:Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, China
         type:PostalAddress
      name:First Hospital of Shanxi Medical University
      address:
         name:Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, China
         type:PostalAddress
      name:First Hospital of Shanxi Medical University
      address:
         name:Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, China
         type:PostalAddress
      name:First Hospital of Shanxi Medical University
      address:
         name:Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, China
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Ma Zhifang
      affiliation:
            name:First Hospital of Shanxi Medical University
            address:
               name:Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, China
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Wei Liang
      affiliation:
            name:First Hospital of Shanxi Medical University
            address:
               name:Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, China
               type:PostalAddress
            type:Organization
      name:Zhang Wei
      affiliation:
            name:First Hospital of Shanxi Medical University
            address:
               name:Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, China
               type:PostalAddress
            type:Organization
      name:Hao Bin
      affiliation:
            name:First Hospital of Shanxi Medical University
            address:
               name:Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, China
               type:PostalAddress
            type:Organization
      name:Tu Rui
      affiliation:
            name:First Hospital of Shanxi Medical University
            address:
               name:Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, China
               type:PostalAddress
            type:Organization
      name:Wu Nan
      affiliation:
            name:First Hospital of Shanxi Medical University
            address:
               name:Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, China
               type:PostalAddress
            type:Organization
      name:Zhang Shuhai
      affiliation:
            name:First Hospital of Shanxi Medical University
            address:
               name:Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, China
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, China
      name:Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, China
      name:Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, China
      name:Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, China
      name:Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, China
      name:Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, China
      name:Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, China

External Links {🔗}(150)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

CDN Services {📦}

  • Crossref

4.52s.